Matches in SemOpenAlex for { <https://semopenalex.org/work/W2954643276> ?p ?o ?g. }
- W2954643276 endingPage "1029" @default.
- W2954643276 startingPage "1029" @default.
- W2954643276 abstract "Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide, but treatment failure and disease recurrence are important causes of adverse outcomes in patients with treatment-requiring ROP (TR-ROP).To apply an automated ROP vascular severity score obtained using a deep learning algorithm and to assess its utility for objectively monitoring ROP regression after treatment.This retrospective cohort study used data from the Imaging and Informatics in ROP consortium, which comprises 9 tertiary referral centers in North America that screen high volumes of at-risk infants for ROP. Images of 5255 clinical eye examinations from 871 infants performed between July 2011 and December 2016 were assessed for eligibility in the present study. The disease course was assessed with time across the numerous examinations for patients with TR-ROP. Infants born prematurely meeting screening criteria for ROP who developed TR-ROP and who had images captured within 4 weeks before and after treatment as well as at the time of treatment were included.The primary outcome was mean (SD) ROP vascular severity score before, at time of, and after treatment. A deep learning classifier was used to assign a continuous ROP vascular severity score, which ranged from 1 (normal) to 9 (most severe), at each examination. A secondary outcome was the difference in ROP vascular severity score among eyes treated with laser or the vascular endothelial growth factor antagonist bevacizumab. Differences between groups for both outcomes were assessed using unpaired 2-tailed t tests with Bonferroni correction.Of 5255 examined eyes, 91 developed TR-ROP, of which 46 eyes met the inclusion criteria based on the available images. The mean (SD) birth weight of those patients was 653 (185) g, with a mean (SD) gestational age of 24.9 (1.3) weeks. The mean (SD) ROP vascular severity scores significantly increased 2 weeks prior to treatment (4.19 [1.75]), peaked at treatment (7.43 [1.89]), and decreased for at least 2 weeks after treatment (4.00 [1.88]) (all P < .001). Eyes requiring retreatment with laser had higher ROP vascular severity scores at the time of initial treatment compared with eyes receiving a single treatment (P < .001).This quantitative ROP vascular severity score appears to consistently reflect clinical disease progression and posttreatment regression in eyes with TR-ROP. These study results may have implications for the monitoring of patients with ROP for treatment failure and disease recurrence and for determining the appropriate level of disease severity for primary treatment in eyes with aggressive disease." @default.
- W2954643276 created "2019-07-12" @default.
- W2954643276 creator A5009286480 @default.
- W2954643276 creator A5012708584 @default.
- W2954643276 creator A5013498181 @default.
- W2954643276 creator A5033034428 @default.
- W2954643276 creator A5037620955 @default.
- W2954643276 creator A5039535916 @default.
- W2954643276 creator A5042038501 @default.
- W2954643276 creator A5049608028 @default.
- W2954643276 creator A5049931304 @default.
- W2954643276 creator A5054028651 @default.
- W2954643276 creator A5069445812 @default.
- W2954643276 creator A5083261801 @default.
- W2954643276 date "2019-09-01" @default.
- W2954643276 modified "2023-10-18" @default.
- W2954643276 title "A Quantitative Severity Scale for Retinopathy of Prematurity Using Deep Learning to Monitor Disease Regression After Treatment" @default.
- W2954643276 cites W1896852452 @default.
- W2954643276 cites W1974052518 @default.
- W2954643276 cites W1986657813 @default.
- W2954643276 cites W2007763447 @default.
- W2954643276 cites W2108989927 @default.
- W2954643276 cites W2111073489 @default.
- W2954643276 cites W2113170046 @default.
- W2954643276 cites W2134440316 @default.
- W2954643276 cites W2139769620 @default.
- W2954643276 cites W2153033813 @default.
- W2954643276 cites W2167431761 @default.
- W2954643276 cites W2189971045 @default.
- W2954643276 cites W2197826519 @default.
- W2954643276 cites W2298072637 @default.
- W2954643276 cites W2332981639 @default.
- W2954643276 cites W2338036999 @default.
- W2954643276 cites W2394656367 @default.
- W2954643276 cites W2402115649 @default.
- W2954643276 cites W2420003563 @default.
- W2954643276 cites W2425036628 @default.
- W2954643276 cites W2507467374 @default.
- W2954643276 cites W2521130223 @default.
- W2954643276 cites W2560288479 @default.
- W2954643276 cites W2568585884 @default.
- W2954643276 cites W2602944657 @default.
- W2954643276 cites W2604287376 @default.
- W2954643276 cites W2615077572 @default.
- W2954643276 cites W2741822194 @default.
- W2954643276 cites W2798153203 @default.
- W2954643276 cites W2800012666 @default.
- W2954643276 cites W2806364329 @default.
- W2954643276 cites W2898192966 @default.
- W2954643276 cites W2900706485 @default.
- W2954643276 cites W2901661131 @default.
- W2954643276 cites W2953404818 @default.
- W2954643276 cites W3148465273 @default.
- W2954643276 cites W3206739941 @default.
- W2954643276 cites W4236388884 @default.
- W2954643276 cites W4248231685 @default.
- W2954643276 cites W4292489196 @default.
- W2954643276 cites W4292528167 @default.
- W2954643276 doi "https://doi.org/10.1001/jamaophthalmol.2019.2442" @default.
- W2954643276 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6613298" @default.
- W2954643276 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31268499" @default.
- W2954643276 hasPublicationYear "2019" @default.
- W2954643276 type Work @default.
- W2954643276 sameAs 2954643276 @default.
- W2954643276 citedByCount "50" @default.
- W2954643276 countsByYear W29546432762019 @default.
- W2954643276 countsByYear W29546432762020 @default.
- W2954643276 countsByYear W29546432762021 @default.
- W2954643276 countsByYear W29546432762022 @default.
- W2954643276 countsByYear W29546432762023 @default.
- W2954643276 crossrefType "journal-article" @default.
- W2954643276 hasAuthorship W2954643276A5009286480 @default.
- W2954643276 hasAuthorship W2954643276A5012708584 @default.
- W2954643276 hasAuthorship W2954643276A5013498181 @default.
- W2954643276 hasAuthorship W2954643276A5033034428 @default.
- W2954643276 hasAuthorship W2954643276A5037620955 @default.
- W2954643276 hasAuthorship W2954643276A5039535916 @default.
- W2954643276 hasAuthorship W2954643276A5042038501 @default.
- W2954643276 hasAuthorship W2954643276A5049608028 @default.
- W2954643276 hasAuthorship W2954643276A5049931304 @default.
- W2954643276 hasAuthorship W2954643276A5054028651 @default.
- W2954643276 hasAuthorship W2954643276A5069445812 @default.
- W2954643276 hasAuthorship W2954643276A5083261801 @default.
- W2954643276 hasBestOaLocation W29546432761 @default.
- W2954643276 hasConcept C126322002 @default.
- W2954643276 hasConcept C167135981 @default.
- W2954643276 hasConcept C187212893 @default.
- W2954643276 hasConcept C2776694085 @default.
- W2954643276 hasConcept C2777802072 @default.
- W2954643276 hasConcept C2778376644 @default.
- W2954643276 hasConcept C2779234561 @default.
- W2954643276 hasConcept C2779531571 @default.
- W2954643276 hasConcept C2779918416 @default.
- W2954643276 hasConcept C54355233 @default.
- W2954643276 hasConcept C71924100 @default.
- W2954643276 hasConcept C86803240 @default.
- W2954643276 hasConceptScore W2954643276C126322002 @default.
- W2954643276 hasConceptScore W2954643276C167135981 @default.